Opportunity ID: 331601

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-21-178
Funding Opportunity Title: Drug Development Tools Research Grants (U01) Clinical Trial Optional
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Consumer Protection
Food and Nutrition
Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards: 30
Assistance Listings: 93.103 — Food and Drug Administration Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 3
Posted Date: Feb 18, 2021
Last Updated Date: Apr 29, 2022
Original Closing Date for Applications: May 25, 2021 Application Due Date(s)

May 25, 2021 by 11:59 PM Eastern Time

May 3, 2022 by 11:59 PM Eastern Time

May 3, 2023 by 11:59 PM Eastern Time

Current Closing Date for Applications: May 03, 2023 Application Due Date(s)May 25, 2021 by 11:59 PM Eastern Time May 17, 2022 by 11:59 PM Eastern Time May 3, 2023 by 11:59 PM Eastern Time
Archive Date: Jun 02, 2023
Estimated Total Program Funding:
Award Ceiling: $250,000
Award Floor: $10,000

Eligibility

Eligible Applicants: Public housing authorities/Indian housing authorities
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Small businesses
Native American tribal governments (Federally recognized)
Special district governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
County governments
Private institutions of higher education
City or township governments
State governments
Public and State controlled institutions of higher education
Independent school districts
Native American tribal organizations (other than Federally recognized tribal governments)
For profit organizations other than small businesses
Additional Information on Eligibility: Eligible OrganizationsHigher Education InstitutionsPublic/State Controlled Institutions of Higher Education Private Institutions of Higher Education The following types of Higher Education Institutions are always encouraged to apply for FDA support as Public or Private Institutions of Higher Education: Hispanic-serving Institutions Historically Black Colleges and Universities (HBCUs) Tribally Controlled Colleges and Universities (TCCUs) Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISIs) Nonprofits Other Than Institutions of Higher EducationNonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education) Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education) For-Profit OrganizationsSmall Businesses For-Profit Organizations (Other than Small Businesses) GovernmentsState Governments County Governments City or Township Governments Special District Governments Indian/Native American Tribal Governments (Federally Recognized) Indian/Native American Tribal Governments (Other than Federally Recognized) U.S. Territory or Possession OtherIndependent School Districts Public Housing Authorities/Indian Housing Authorities Native American Tribal Organizations (other than Federally recognized tribal governments) Faith-based or Community-based Organizations Regional Organizations

Additional Information

Agency Name: Food and Drug Administration
Description:

The purpose of this funding opportunity announcement (FOA) is to support research to continue the development of drug development tools that have an accepted Letter of Intent (LOI) within a drug development tool qualification program within either CBER or CDER.

The grants will be used to further the development of tools that, once qualified, will be made publicly available to fill unmet needs in drug development.

Link to Additional Information: PAR-21-178 – FULL ANNOUNCEMENT
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Shashi Malhotra

Grants Management Specialist

Phone 2404027592
Email:shashi.malhotra@fda.hhs.gov

Version History

Version Modification Description Updated Date
Extend Due Date for 2022 to May 17, 2022 Apr 29, 2022
Correct Due date Feb 18, 2021
Feb 18, 2021

DISPLAYING: Synopsis 3

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-21-178
Funding Opportunity Title: Drug Development Tools Research Grants (U01) Clinical Trial Optional
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Consumer Protection
Food and Nutrition
Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards: 30
Assistance Listings: 93.103 — Food and Drug Administration Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 3
Posted Date: Feb 18, 2021
Last Updated Date: Apr 29, 2022
Original Closing Date for Applications: May 25, 2021 Application Due Date(s)

May 25, 2021 by 11:59 PM Eastern Time

May 3, 2022 by 11:59 PM Eastern Time

May 3, 2023 by 11:59 PM Eastern Time

Current Closing Date for Applications: May 03, 2023 Application Due Date(s)May 25, 2021 by 11:59 PM Eastern Time May 17, 2022 by 11:59 PM Eastern Time May 3, 2023 by 11:59 PM Eastern Time
Archive Date: Jun 02, 2023
Estimated Total Program Funding:
Award Ceiling: $250,000
Award Floor: $10,000

Eligibility

Eligible Applicants: Public housing authorities/Indian housing authorities
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Small businesses
Native American tribal governments (Federally recognized)
Special district governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
County governments
Private institutions of higher education
City or township governments
State governments
Public and State controlled institutions of higher education
Independent school districts
Native American tribal organizations (other than Federally recognized tribal governments)
For profit organizations other than small businesses
Additional Information on Eligibility: Eligible OrganizationsHigher Education InstitutionsPublic/State Controlled Institutions of Higher Education Private Institutions of Higher Education The following types of Higher Education Institutions are always encouraged to apply for FDA support as Public or Private Institutions of Higher Education: Hispanic-serving Institutions Historically Black Colleges and Universities (HBCUs) Tribally Controlled Colleges and Universities (TCCUs) Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISIs) Nonprofits Other Than Institutions of Higher EducationNonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education) Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education) For-Profit OrganizationsSmall Businesses For-Profit Organizations (Other than Small Businesses) GovernmentsState Governments County Governments City or Township Governments Special District Governments Indian/Native American Tribal Governments (Federally Recognized) Indian/Native American Tribal Governments (Other than Federally Recognized) U.S. Territory or Possession OtherIndependent School Districts Public Housing Authorities/Indian Housing Authorities Native American Tribal Organizations (other than Federally recognized tribal governments) Faith-based or Community-based Organizations Regional Organizations

Additional Information

Agency Name: Food and Drug Administration
Description:

The purpose of this funding opportunity announcement (FOA) is to support research to continue the development of drug development tools that have an accepted Letter of Intent (LOI) within a drug development tool qualification program within either CBER or CDER.

The grants will be used to further the development of tools that, once qualified, will be made publicly available to fill unmet needs in drug development.

Link to Additional Information: PAR-21-178 – FULL ANNOUNCEMENT
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Shashi Malhotra

Grants Management Specialist

Phone 2404027592
Email:shashi.malhotra@fda.hhs.gov

DISPLAYING: Synopsis 2

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-21-178
Funding Opportunity Title: Drug Development Tools Research Grants (U01) Clinical Trial Optional
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Consumer Protection
Food and Nutrition
Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards: 30
Assistance Listings: 93.103 — Food and Drug Administration Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Feb 18, 2021
Last Updated Date: Feb 18, 2021
Original Closing Date for Applications:
Current Closing Date for Applications: May 03, 2023 Application Due Date(s)May 25, 2021 by 11:59 PM Eastern Time May 3, 2022 by 11:59 PM Eastern TimeMay 3, 2023 by 11:59 PM Eastern Time
Archive Date: Jun 02, 2023
Estimated Total Program Funding:
Award Ceiling: $250,000
Award Floor: $10,000

Eligibility

Eligible Applicants: Independent school districts
Public housing authorities/Indian housing authorities
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Special district governments
Private institutions of higher education
State governments
For profit organizations other than small businesses
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
City or township governments
Public and State controlled institutions of higher education
County governments
Small businesses
Native American tribal governments (Federally recognized)
Additional Information on Eligibility: Eligible OrganizationsHigher Education InstitutionsPublic/State Controlled Institutions of Higher Education Private Institutions of Higher Education The following types of Higher Education Institutions are always encouraged to apply for FDA support as Public or Private Institutions of Higher Education: Hispanic-serving Institutions Historically Black Colleges and Universities (HBCUs) Tribally Controlled Colleges and Universities (TCCUs) Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISIs) Nonprofits Other Than Institutions of Higher EducationNonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education) Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education) For-Profit OrganizationsSmall Businesses For-Profit Organizations (Other than Small Businesses) GovernmentsState Governments County Governments City or Township Governments Special District Governments Indian/Native American Tribal Governments (Federally Recognized) Indian/Native American Tribal Governments (Other than Federally Recognized) U.S. Territory or Possession OtherIndependent School Districts Public Housing Authorities/Indian Housing Authorities Native American Tribal Organizations (other than Federally recognized tribal governments) Faith-based or Community-based Organizations Regional Organizations

Additional Information

Agency Name: Food and Drug Administration
Description:

The purpose of this funding opportunity announcement (FOA) is to support research to continue the development of drug development tools that have an accepted Letter of Intent (LOI) within a drug development tool qualification program within either CBER or CDER.

The grants will be used to further the development of tools that, once qualified, will be made publicly available to fill unmet needs in drug development.

Link to Additional Information: PAR-21-178 – FULL ANNOUNCEMENT
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Shashi Malhotra

Grants Management Specialist

Phone 2404027592
Email:shashi.malhotra@fda.hhs.gov

DISPLAYING: Synopsis 1

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-21-178
Funding Opportunity Title: Drug Development Tools Research Grants (U01) Clinical Trial Optional
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Consumer Protection
Food and Nutrition
Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards: 30
Assistance Listings: 93.103 — Food and Drug Administration Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Feb 18, 2021
Last Updated Date: Feb 18, 2021
Original Closing Date for Applications:
Current Closing Date for Applications: May 25, 2021 Application Due Date(s)

May 25, 2021 by 11:59 PM Eastern Time

May 3, 2022 by 11:59 PM Eastern Time

May 3, 2023 by 11:59 PM Eastern Time

Archive Date: Jun 24, 2021
Estimated Total Program Funding:
Award Ceiling: $250,000
Award Floor: $10,000

Eligibility

Eligible Applicants: Independent school districts
Public housing authorities/Indian housing authorities
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Special district governments
Private institutions of higher education
State governments
For profit organizations other than small businesses
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
City or township governments
Public and State controlled institutions of higher education
County governments
Small businesses
Native American tribal governments (Federally recognized)
Additional Information on Eligibility: Eligible Organizations
Higher Education Institutions

Public/State Controlled Institutions of Higher Education
Private Institutions of Higher Education
The following types of Higher Education Institutions are always encouraged to apply for FDA support as Public or Private Institutions of Higher Education:

Hispanic-serving Institutions
Historically Black Colleges and Universities (HBCUs)
Tribally Controlled Colleges and Universities (TCCUs)
Alaska Native and Native Hawaiian Serving Institutions
Asian American Native American Pacific Islander Serving Institutions (AANAPISIs)
Nonprofits Other Than Institutions of Higher Education

Nonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education)
Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education)
For-Profit Organizations

Small Businesses
For-Profit Organizations (Other than Small Businesses)
Governments

State Governments
County Governments
City or Township Governments
Special District Governments
Indian/Native American Tribal Governments (Federally Recognized)
Indian/Native American Tribal Governments (Other than Federally Recognized)
U.S. Territory or Possession
Other

Independent School Districts
Public Housing Authorities/Indian Housing Authorities
Native American Tribal Organizations (other than Federally recognized tribal governments)
Faith-based or Community-based Organizations
Regional Organizations

Additional Information

Agency Name: Food and Drug Administration
Description:

The purpose of this funding opportunity announcement (FOA) is to support research to continue the development of drug development tools that have an accepted Letter of Intent (LOI) within a drug development tool qualification program within either CBER or CDER.

The grants will be used to further the development of tools that, once qualified, will be made publicly available to fill unmet needs in drug development.

Link to Additional Information: PAR-21-178 – FULL ANNOUNCEMENT
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Shashi Malhotra

Grants Management Specialist

Phone 2404027592
Email:shashi.malhotra@fda.hhs.gov

Related Documents

Packages

Agency Contact Information: Shashi Malhotra
Grants Management Specialist
Phone 2404027592
Email: shashi.malhotra@fda.hhs.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
93.103 PAR-21-178-FORMS-G FORMS G – For due dates on or after January 25, 2022 PKG00270076 Nov 12, 2021 Nov 24, 2022 View
93.103 PAR-21-178-FORMS-H FORMS H – For due dates on or after January 25, 2023 PKG00278676 Nov 24, 2022 May 03, 2023 View

Package 1

Mandatory forms

331601 RR_SF424_5_0-5.0.pdf

331601 PHS398_CoverPageSupplement_5_0-5.0.pdf

331601 RR_OtherProjectInfo_1_4-1.4.pdf

331601 PerformanceSite_4_0-4.0.pdf

331601 RR_KeyPersonExpanded_4_0-4.0.pdf

331601 RR_Budget_3_0-3.0.pdf

331601 PHS398_ResearchPlan_4_0-4.0.pdf

331601 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

331601 RR_SubawardBudget30_3_0-3.0.pdf

331601 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 2

Mandatory forms

331601 RR_SF424_5_0-5.0.pdf

331601 PHS398_CoverPageSupplement_5_0-5.0.pdf

331601 RR_OtherProjectInfo_1_4-1.4.pdf

331601 PerformanceSite_4_0-4.0.pdf

331601 RR_KeyPersonExpanded_4_0-4.0.pdf

331601 RR_Budget_3_0-3.0.pdf

331601 PHS398_ResearchPlan_5_0-5.0.pdf

331601 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

331601 RR_SubawardBudget30_3_0-3.0.pdf

331601 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-11T06:40:28-05:00

Share This Post, Choose Your Platform!

About the Author: